Possible Mechanisms of Amyloid β‐Protein Protofibrils for Acceleration of Aggregation
Possible Mechanisms of Amyloid β‐Protein Protofibrils for Acceleration of Aggregation
About this item
Full title
Author / Creator
Publisher
Hoboken: John Wiley and Sons Inc
Journal title
Language
English
Formats
Publication information
Publisher
Hoboken: John Wiley and Sons Inc
Subjects
More information
Scope and Contents
Contents
Background
The growing number of AD patients is a public concern all over the world. During the decade, anti‐amyloid beta‐proteins (Aβ) monoclonal antibodies for AD patients have been developed. Among the immunotherapeutic agents, lecanemab is an anti‐Aβ monoclonal antibody that binds to Aβ protofibrils (Aβ PFs), which is an intermediate molecul...
Alternative Titles
Full title
Possible Mechanisms of Amyloid β‐Protein Protofibrils for Acceleration of Aggregation
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11709583
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11709583
Other Identifiers
ISSN
1552-5260
E-ISSN
1552-5279
DOI
10.1002/alz.085834
